Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year.
Details →
Duodenal cancer is a rare but serious malignancy that develops in the first portion of your small intestine (duodenum), accounting for less than 1% of all gastrointestinal cancers [3].
Details →
Cancer cells may break away from a tumor in the colon or rectum and spread to other parts of the body through the bloodstream or lymphatic system. These cells may settle and form new tumors on a different organ
Details →
Colon cancer (ICD C18) is one of the five most common malignant tumors in the world, ranking third overall. While the average age of most patients is 60-75 years, the disease can also develop in individuals between 35-50 years old.
Details →
Pancreatic cancer is an aggressive tumor of the digestive system. One of the reasons for the low effectiveness of treatment for pancreatic tumors is the weak anti-tumor immune response.
Details →
A Klatskin tumor, also known as perihilar cancer, is a type of extrahepatic cholangiocarcinoma, which starts in the area where the right and left bile ducts converge to form the common bile duct.
Details →
Kidney cancer, particularly renal cell carcinoma (RCC), remains a formidable challenge, necessitating innovative treatments to enhance outcomes for kidney cancer patients.
Details →
Conventional treatment for pulmonary fibrosis offers limited hope, slowing progression but never reversing damage or restoring lung function.
Details →
Kidney cancer, particularly renal cell carcinoma (RCC), is a significant health challenge requiring innovative approaches to improve outcomes for kidney cancer patients.
Details →
Lung cancer, one of the leading causes of cancer-related deaths globally, demands innovative approaches to improve survival rates and quality of life.
Details →
Dendritic cell therapy, a cornerstone of modern immunotherapy, is revolutionizing cancer treatment by harnessing the immune system to target tumors.
Details →
Dendritic cells, often dubbed the immune system’s generals, play a pivotal role in directing anti-cancer attacks, offering hope for patients battling various malignancies.
Details →
The quality ofhealthcare in some countries is not able to always satisfy the needs of its citizens. People cannot receive adequate care in severe cases or when suffering from a rare disease.
Details →
Multiple myeloma is a malignancy of plasma cells in the bone marrow, leading to bone destruction, kidney impairment, and weakened immunity.
Details →
While traditional approaches like radiation therapy and chemotherapy show limited effectiveness, modern immunotherapy has revolutionized treatment outcomes at all stages.
Details →
Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person.
Details →
Over 400,000 new cases of bladder cancer are diagnosed in the world annually. In 75% of patients, the tumor is detected at an early localized stage.
Details →
Colorectal cancer develops in the colon or rectum when abnormal cells grow uncontrollably, often starting as benign polyps that turn malignant.
Details →
Glioblastoma is a malignant neoplasm that arises from glial cells of the brain. The tumor is heterogeneous and requires a differentiated therapeutic approach.
Details →
